SCHEMBL636948

SCHEMBL636948

O=[C]OC(c1ccc2c(c1)OCO2)[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
MTOR P42345 1/20 0.41
VCP P55072 1/20 0.41
CYP1A2 P05177 3/20 0.41
CYP3A4 P08684 3/20 0.41
CYP2D6 P10635 3/20 0.41
CYP2C9 P11712 3/20 0.41
CYP2C19 P33261 3/20 0.41
MAPK1 P28482 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
HIF1A Q16665 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KMT2A Q03164 5/20 0.41
MEN1 O00255 4/20 0.41
MAPT P10636 2/20 0.40
GAA P10253 1/20 0.40
ACHE P22303 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14829845 0.82 KMT2A (0.45) RAB9ANPC1MTORVCPCYP1A2
SCHEMBL636949 0.80 RAB9A (0.44) RAB9ANPC1MTORVCPCYP1A2
SCHEMBL2298417 0.79 GAA (0.46) RAB9ANPC1MTORVCPCYP3A4
SCHEMBL28168165 0.78 MAPT (0.44) RAB9ANPC1MTORVCPCYP1A2
SCHEMBL9562062 0.78 MAPT (0.43) RAB9ANPC1MTORVCPCYP1A2
Methane SCHEMBL28340880 0.77 MAPT (0.42) RAB9ANPC1MTORVCPCYP1A2
Methane SCHEMBL2042661 0.77 MAPT (0.43) RAB9ANPC1MTORVCPCYP1A2
SCHEMBL15049955 0.77 MAPT (0.45) RAB9ANPC1CYP1A2CYP3A4CYP2D6
SCHEMBL9117907 0.76 CYP2D6 (0.48) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL1428266 0.74 GAA (0.49) RAB9ANPC1MTORVCPCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1427743-A4 PROCESS FOR THE SYNTHESIS OF PYRAZOLOPYRIMIDINES EPOCH BIOSCIENCES INC (US) 2007-04-04 EP claimed
EP-1427743-A2 PROCESS FOR THE SYNTHESIS OF PYRAZOLOPYRIMIDINES Epoch Biosciences, Inc. (US) 2004-06-16 EP claimed
WO-2003022859-A2 PROCESS FOR THE SYNTHESIS OF PYRAZOLOPYRIMIDINES EPOCH BIOSCIENCES, INC. (US) 2003-03-20 WO claimed
US-5482867-A Spatially-addressable immobilization of anti-ligands on surfaces AFFYMAX TECHNOLOGIES N.V. (NL) 1996-01-09 US claimed
CN-107108796-B Polymer compound, surface treatment agent, laminate using surface treatment agent, transistor, and method for producing laminate 株式会社尼康 2019-10-01 CN disclosed
CN-107108796-A Polymer compound, surface treatment agent, laminate using surface treatment agent, transistor, and method for producing laminate 株式会社尼康 2017-08-29 CN disclosed
EP-2267165-B1 Nucleic acid sequence analysis GEN PROBE INC (US) 2016-11-30 EP disclosed
EP-2267164-B1 Nucleic acid sequence analysis GEN PROBE INC (US) 2016-09-14 EP disclosed
EP-1229133-B1 Apparatus for nucleic acid sequence analysis GEN PROBE INC (US) 2016-03-09 EP disclosed
WO-2012024558-A2 LIGHT MEDIATED REGULATION OF PROTEIN DIMERIZATION THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2012-02-23 WO disclosed
EP-1017848-B2 NUCLEIC ACID SEQUENCE ANALYSIS GEN PROBE INC (US) 2012-02-22 EP disclosed
US-8034747-B2 Photolabile compound, oligomer probe array and substrate for oligomer probe array containing the same, and manufacturing method of the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2011-10-11 US disclosed
WO-2004027822-A2 ORIENTED NANOSTRUCTURES AND METHODS OF PREPARING NANOSYS, INC. (US) 2004-04-01 WO disclosed
WO-2003085701-A2 METHODS OF POSITIONS AND/OR ORIENTING NANOSTRUCTURES NANOSYS, INC. (US) 2003-10-16 WO disclosed
US-20030186522-A1 Methods of positioning and/or orienting nanostructures NANOSYS, INC. 2003-10-02 US disclosed
EP-1017848-B1 NUCLEIC ACID SEQUENCE ANALYSIS MEDICAL BIOSYSTEMS LTD (GB) 2002-10-09 EP disclosed
EP-1229133-A2 Nucleic acid sequence analysis Medical Biosystems Ltd. (GB) 2002-08-07 EP disclosed
EP-1017848-A2 NUCLEIC ACID SEQUENCE ANALYSIS Medical Biosystems Ltd. (GB) 2000-07-12 EP disclosed
WO-1999005315-A2 NUCLEIC ACID SEQUENCE ANALYSIS MEDICAL BIOSYSTEMS LTD. (GB) 1999-02-04 WO disclosed
WO-1994010128-A1 NOVEL PHOTOREACTIVE PROTECTING GROUPS AFFYMAX TECHNOLOGIES N.V. (AN) 1994-05-11 WO disclosed